Prot# CASM981CUS09: An Investigation of the Safety & Efficacy of Elidel® 1% Cream in Atopic Disease Modification, Assessed in a 3-yr Randomized Double-Blind Vehicle Controlled Phase to Evaluate Effects on Atopic Dermatitis in Infants, & a 2-3 Yr

Project: Research project

Project Details

StatusFinished
Effective start/end date2/8/056/30/11

Funding

  • Novartis Pharmaceuticals Corporation (CASM981CUS09)